ARUP Laboratories has launched the clinical CLARISPECT Multiple Myeloma MRD by Spectral Flow Cytometry assay for multiple ...
A new research perspective titled "Adopted neoplastic cells and the consequences of their existence" has been published in Oncotarget. In this research perspective, researcher Yuri Lazebnik from Lerna ...
“[...] I hope that considering and testing the concept of adopted neoplastic cells will prove to be useful in explaining puzzling observations related to neoplasia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results